ArticleInternational journal of clinical oncology2024

Difference of oncological efficacy between two immune checkpoint inhibitors following first-line platinum-based chemotherapy in patients with unresectable, metastatic, advanced urothelial carcinoma: a multicenter real-world Japanese cohort.

Makito Miyake et al.PubMed ↗Publisher ↗

No numbers read from the abstract.